Skip to main content

Peer Review reports

From: Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Original Submission
9 Jun 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Jul 2022 Reviewed Reviewer Report - Itziar Oyagüez
7 Aug 2022 Reviewed Reviewer Report
22 Aug 2022 Author responded Author comments - Gebremedhin Beedemariam Gebretekle
Resubmission - Version 3
22 Aug 2022 Submitted Manuscript version 3
2 Sep 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
30 Sep 2022 Editorially accepted
29 Oct 2022 Article published 10.1186/s12913-022-08662-3

You can find further information about peer review here.

Back to article page